Skip to main content
. 2021 Oct 7;5(Suppl 2):e12589. doi: 10.1002/rth2.12589
2001 2002 2006 April 2020 August 2020 February 2021
Hemoglobin 11.7–16 mg/dL 12.5 12.8 12.8 11.5 12.7
Platelet count (150–450 x103 cells/µL)

142

199

244

172

149

131

38

43

55

174
Protein C activity (70–130%) 58% 89%
Protein S activity (62–163%) 60% 55%
Protein S Ag free (70–160%) 60%
ADAMTS13 activity < 5%; 9% after 4 plasma exchanges 5
Imaging studies

MRI: Subacute left basal ganglia infarct and acute left parietal lobe infarct

Normal trans‐esophageal echocardiogram

MRI: old left parietal, left caudate, and right frontal (subcortical/parasagittal) infarcts MRI: acute infarction in the right superior frontal gyrus and subacute infarct at the right inferior frontal gyrus with hemorrhagic conversion

CT: Acute right middle

cerebral infarct

Antithrombotic agent Aspirin low‐dose Warfarin INR target 2–3 Enoxaparin to allow for testing protein C and S Warfarin INR 1.8 on admission Apixaban 5 mg twice daily Apixaban 5 mg twice daily
Other Plasma exchange Plasma infusions bi‐monthly